What is Braxia Scientific Corp. (BRAXF) stock price today?

Braxia Scientific Corp. (BRAXF) is currently trading at $0.00.

What is BRAXF P/E ratio?

Braxia Scientific Corp.'s P/E ratio is -0.09. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is BRAXF return on equity (ROE)?

Braxia Scientific Corp.'s return on equity (ROE) is -254.58%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is Braxia Scientific Corp.'s market cap?

Braxia Scientific Corp. has a market capitalization of $28328.

OTC · Biotechnology

Braxia Scientific Corp. (BRAXF) Stock

$0.00 OTC: BRAXF Healthcare

Braxia Scientific Corp. functions as a medical research entity that also runs clinics, offering ketamine therapies to individuals suffering from depression and linked conditions.

Valuation

Metric	Value
Price	$0.00
Market Cap	$28328
P/E Ratio	-0.09
P/B Ratio	0.01
P/S Ratio	0.01
EPS (TTM)	$-0.04
52-Week High	$0.00
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-254.58%
ROA	-42.36%
ROCE	-430.88%
Gross Margin	14.67%
Operating Margin	-174.06%
Net Margin	-650.00%
Debt/Equity	0.00
Current Ratio	0.18

Annual Financials (USD)

Metric	2020	2021	2022	2023
Revenue	$0	$1.0M	$1.0M	$2.0M
Operating Profit	$0	$-11.0M	$-7.0M	$-7.0M
Net Profit	$0	$-89.0M	$-12.0M	$-13.0M
EPS	$0.00	$-0.56	$-0.07	$-0.06
Op Margin	-81353.8%	-1045.4%	-481.4%	-397.0%

Balance Sheet (USD)

Metric	2020	2021	2022	2023
Total Assets	$14.0M	$18.0M	$12.0M	$4.0M
Total Liabilities	$0	$3.0M	$3.0M	$2.0M
Cash	$2.0M	$11.0M	$9.0M	$1.0M
Borrowings	$0	$0	$0	$0

Cash Flow (USD)

Metric	2020	2021	2022	2023
Operating Cash Flow	$0	$-5.0M	$-5.0M	$-7.0M
Investing Cash Flow	$0	$-1.0M	$-1.0M	$-2.0M
Financing Cash Flow	$1.0M	$0	$0	$0
Net Cash Flow	$1.0M	$11.0M	$-2.0M	$-7.0M
Free Cash Flow	$0	$-5.0M	$-5.0M	$-8.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-0.01
FCF Yield	-586.11%
Quick Ratio	1.00
Interest Coverage	-419.27
Return 1Y	-92.19%
Return 3Y	-99.19%
Return 5Y	—

Ownership

Insiders Held0.00%

Institutions Held0.00%

Institutions Float Held0.00%

Institutional Holder	Shares	Report Date
Curio Wealth, LLC	1,000	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ACBMAcro Biomedical Co., Ltd.	$0.03	+0.00%	-11.30	$1.56M	0.00%
ARYCArrayit Corporation	$0.00	—	0.00	$7935	0.00%
AVXTAVAX Technologies, Inc.	$0.00	—	0.00	$6894	0.00%
DNAGDNAPrint Genomics, Inc.	$0.00	—	—	$12892	0.00%
EHOSEhouse Global, Inc.	$0.00	—	0.00	$10127	0.00%

About Braxia Scientific Corp.

Braxia Scientific Corp. functions as a medical research entity that also runs clinics, offering ketamine therapies to individuals suffering from depression and linked conditions. Beyond its clinical services, the company is actively engaged in discovering and bringing to market novel pharmaceutical compounds and innovative delivery methods. Leveraging its intellectual property development platform, Braxia Scientific innovates by developing derivatives of ketamine and psilocybin, in addition to other psychedelic substances. The organization further owns and operates several multidisciplinary clinics focused on treating a broad spectrum of mental health disorders. Braxia Scientific Corp.'s main office is located in Mississauga, Ontario.

Braxia Scientific Corp. (BRAXF) stock trades at $0.00 with a market capitalization of $28328. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.09, reflecting a net loss over the last twelve months, price-to-book of 0.01, price-to-sales of 0.01.

On profitability, Braxia Scientific Corp. generates a return on equity (ROE) of -254.58% (negative, reflecting a net loss), return on capital employed of -430.88%, an operating margin of -174.06%, a net profit margin of -650.00%.

Official website: www.braxiascientific.com